Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline Characteristics

INTRODUCTION: The phase 3 PSO LONG study (NCT02899962) demonstrated superior efficacy of proactive (PM) versus reactive management (RM) using calcipotriene 0.005%/betamethasone dipropionate 0.064% (Cal/BD) foam in adults with psoriasis. Here, we evaluated whether certain baseline parameters had an e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebwohl, Mark G., Papp, Kim A., Mørch, Marie Holst, Bernasconi, Marie Y. Jablonski, Warren, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484403/
https://www.ncbi.nlm.nih.gov/pubmed/34339017
http://dx.doi.org/10.1007/s13555-021-00585-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484403/
https://www.ncbi.nlm.nih.gov/pubmed/34339017
http://dx.doi.org/10.1007/s13555-021-00585-x

Ejemplares similares